Early warning probe could save lives after pancreatic surgery
NCT ID NCT03631173
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new monitoring method for patients who have had pancreatic surgery. After surgery, a thin probe is placed near the surgical connection to measure chemicals that may signal a leak before symptoms appear. Half of the 201 participants will receive this monitoring to see if it reduces hospital stays and complications.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BILIARY TRACT CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Oslo University Hospital
Oslo, 0424, Norway
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a vaccine help fight Hard-to-Treat cancers?
- Blood and gut clues may flag pancreatic cancer risk early
- A high-tech camera may take the guesswork out of spotting a dangerous surgery complication
- Can a new imaging trick spot pancreatic cancer without a biopsy?
- MRI might reveal hidden pancreatic risks in obesity
- Can a new PET tracer light up hidden cancers?